Efficacy and safety of anti-thrombotic therapy after surgical mitral valve repair: a scoping review
Background Mitral valve repair (MVr) is the gold standard treatment for degenerative mitral regurgitation, yet there is ongoing controversy regarding optimal anti-thrombotic therapy post-MVr. This scoping review aimed to summarise current evidence on the safety and efficacy of anti-thrombotic therap...
Saved in:
| Main Authors: | Jian Ye, Jenny Chen, Hazal Ece Babadagli, Ricky Turgeon, Erica HZ Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-01-01
|
| Series: | Open Heart |
| Online Access: | https://openheart.bmj.com/content/12/1/e003158.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitral Valve Repair
by: Irbaz Hameed, MD, et al.
Published: (2025-03-01) -
Why do surgical mitral valve repairs fail?Central Message
by: Gilles Dreyfus, PhD, et al.
Published: (2024-06-01) -
Native mitral valve endocarditis: Robotic cardiac surgical repairCentral Message
by: Robinson Poffo, MD, MSc, et al.
Published: (2024-02-01) -
Retrospective Evaluation of Transcatheter Edge‐To‐Edge Mitral Valve Repair in Dogs With Myxomatous Mitral Valve Disease
by: Jeong‐Min Lee, et al.
Published: (2025-07-01) -
Clinical Outcomes of Mitral Valve Repair in Dogs With Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease
by: Tomohiko Yoshida, et al.
Published: (2025-05-01)